Register now for the 21st CIMT Annual Meeting. Take advantage of our advance registration discount. Go to meeting.cimt.eu to register for Europe's Cancer Immunotherapy Meeting. #cancerimmunotherapy

Register for the 21st CIMT Annual Meeting and hear from Jing Chen UChicago Medicine about the influence of nutrition in cancer therapies and recent findings on the effects of dietary nutrients on reprogramming of CD8+ T cells to increase anti-tumor immunity. meeting.cimt.eu

At the 21st CIMT Annual Meeting Rafet Rafet Basar MD Anderson Cancer Center will present methods to enhance the potency of NK cellular therapy products using state of the art genetic engineering strategies. To register for #CIMT2024, go to meeting.cimt.eu

Register today for #CICON24, presented by CRI and ENCI, in conjunction with ENCI partner organizations, Cancer Immunotherapy, EATI, NIBIT, and GÉTICA! Sign up to attend the conference, held September 8-11, 2024, in National Harbor, MD: bit.ly/49Bceq8 #CancerResearch #CICON

Are you a PhD student or postdoc with a research focus in cellular immunotherapies? Apply by June 14 to present your work, connect with peers and scientific leaders in an extraordinary retreat setting in Portugal. cimt.eu/summer-school

Register by July 15, and save with early-bird discounts for #CICON24, presented by CRI and ENCI, in conjunction with ENCI partner organizations, Cancer Immunotherapy, EATI, NIBIT, and GÉTICA! Sign up to attend the conference, held from September 8-11, 2024: bit.ly/49Bceq8

The Eighth International Cancer Immunotherapy Conference kicks off this morning! Joining the Cancer Research Institute and ENCI in National Harbor, MD today? Share your own photos and content from the conference, using the hashtag #CICON24 to be reposted!

During #CICON24's first session, Memorial Sloan Kettering Cancer Center's Dr. Luis Diaz Jr. dove into the groundbreaking potential of immunoablative neoadjuvant therapy, an approach that uses the power of the immune system to target and shrink tumors before surgery, offering new hope to patients.

Understand why conferences such as #CICON24 are so critical for sharing scientific data and discoveries, according to Dr. Amanda Lund of NYU Langone Health Amanda Lund Lab, a 2019 CRI Lloyd J. Old STAR class member. #Immunotherapy #CancerResearch

During the second session of #CICON24, CRI-Immuno-Informatics Fellow Dr. Qin Zhu UC San Francisco joined us to explore how machine learning and advanced technologies are allowing him study T cell state and identify mechanisms that can drive them to become effector T cells. #MachineLearning

Discover the groundbreaking research and collaboration that's driving the future of cancer immunotherapy, in our daily recap blog from the first day of #CICON24, presented by CRI and ENCI, in conjunction with Cancer Immunotherapy, EATI, NIBIT, and GÉTICA: bit.ly/47l3TXz

"We're back with the next level- the next generation of science. Now, we have to take that science, and translate it into the next generation of immunotherapies," emphasizes CRI Scientific Advisory Council Associate Director Dr. Elizabeth Jaffee Johns Hopkins Medicine, at #CICON24.

To young researchers at #CICON24 who are navigating their futures in the field of cancer research, Memorial Sloan Kettering Cancer Center's Dr. Dana Pe'er emphasizes, "You need to follow your passion, because passion drives ideas. Passion drives innovation." #CancerResearch #Immunotherapy

During an exclusive interview from the second day of #CICON24, Dr. Andrew Koh from UT Southwestern Medical Center describes what excites him most about the current state of cancer immunotherapy! #Immunotherapy #CancerResearch

Explore cancer vaccines, immune health, and future therapies in our recap blog of the sessions and discussions that took place during the second day of #CICON24! Read now: bit.ly/4ek9srJ #CancerResearch #Immunotherapy #CancerVaccines

Following her presentation on fibrolamellar hepatocellular carcinoma, CRI Clinical Innovator Dr. Marina Baretti Johns Hopkins Medicine sat down with the Cancer Research Institute to share how the scientific discoveries being discussed at #CICON24 have immediate, real world application.

CRI Lloyd J. Old STAR Dr. Ping-Chih Ho HoLab of Université de Lausanne Ludwig Cancer describes how the environment at #CICON24 naturally lends itself to collaboration and creative problem solving. #CancerResearch #Immunotherapy

Dr. Kevin Wang Penn shares his excitement about attending and presenting at #CICON24, from the supportive atmosphere, to the cutting-edge research showcased, and the opportunities it has provided for collaboration and growth in the field of cancer immunotherapy. #Immunotherapy

#CICON24 wrapped up on September 11, 2024, in National Harbor, MD, showcasing breakthrough advancements that are set to transform cancer treatment. Discover 5 key takeaways from the conference, in our recap blog: bit.ly/47ss0nk #CancerResearch #Immunotherapy

Luis Diaz Jr. discusses the potential of immunoablative neoadjuvant therapy at CICON24 - Cancer Research Institute Memorial Sloan Kettering Cancer Center oncodaily.com/blog/140970 #CICON24 #Cancer #CancerResearch #MedEd #MedNews #Health #Medicine #MedTwitter #OncoDaily #Oncology